Matches 1 - 50 out of 120 1 2 3 >
Match Document Document Title
US20090246277 Controlled release system  
The invention relates to a system for controlled release of medicinally active substances, which comprises sucrose acetate isobutyrate (SAIB) and a further solvent.
US20090220593 EXTENDED RELEASE DOSAGE FORMS OF QUETIAPINE  
The present invention relates to multiple unit extended release dosage forms of quetiapine for oral administration, wherein each unit comprises a core containing quetiapine and one or more of...
US20090214644 TRANEXAMIC ACID FORMULATIONS WITH REDUCED ADVERSE EFFECTS  
Disclosed are delayed release oral tranexamic acid formulations and methods of treatment therewith.
US20090214643 IMPROVED PHARMACOKINETIC PROFILE OF BETA-ADRENERGIC INVERSE AGONISTS FOR THE TREATMENT OF PULMONARY AIRWAY DISEASES  
Methods for administering beta-adrenergic inverse agonists with improved pharmacokinetic profiles for the treatment of pulmonary airway diseases are disclosed. The beta adrenergic inverse agonists...
US20090214642 COATED FORMULATIONS FOR TOLTERODINE  
A sustained release pharmaceutical composition comprising coating comprising at least one water-insoluble permeable polymer and at least one water soluble polymer and homogenous cores containing...
US20090208570 Extended Release Dosage forms of Metoprolol  
The present invention relates to extended release dosage forms of metoprolol or salts thereof comprising a water insoluble and non-swellable inert core and one or more pharmaceutically acceptable...
US20090202635 Delivery System, Application, and Method  
A sequenced biologically compatible delivery system, application, and method is provided, which increases therapeutic care of animals by conveniently and effectively supplying meticulous...
US20090202634 PHARMACEUTICAL DOSAGE FORM  
The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very...
US20090202633 Extended release formulations of guaifenesin  
The present invention relates to extended release formulations comprising expectorant. More particularly, the present invention relates to extended release formulations comprising guaifenesin. The...
US20090202629 Controlled release hydrocodone formulations  
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
US20090196923 CONTROLLED RELEASE FORMULATION COMPRISING ANTI-EPILEPTIC DRUGS  
The present invention relates to pharmaceutical formulation of antiepileptic drug preferably oxcarbazepine. The formulation comprises multiple tablets or pellets of immediate release or controlled...
US20090196921 Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition  
Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of...
US20090169616 FORMULATION AND METHOD FOR THE RELEASE OF PAROXETINE IN THE LARGE INTESTINE  
The present invention provides a delayed and/or controlled release formulation of paroxetine or a pharmaceutically acceptable salt thereof that is formulated to release a substantial portion of the...
US20090162433 METHOD OF TREATMENT  
The invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the reduction of urgency in patients suffering from...
US20090155361 TABLET WITH MULTIPLE DRUG-CONTAINING SECTIONS  
A tablet which is either a two-layer tablet comprising a layer A and a layer B or a three-layer tablet comprising a layer A, a layer B and a layer C in that order, wherein the layer B is a...
US20090155357 Alcohol Resistant Pharmaceutical Formulations  
The present invention provides alcohol resistant oral dosage pharmaceutical forms and methods of using such oral dosage forms to avoid dose dumping if the dosage form is taken together with alcohol.
US20090123540 Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof  
A particulate SAE-CD composition is provided. The SAE-CD composition has an advantageous combination of physical properties not found in known solid forms of SAECD. In particular, the SAE-CD...
US20090123535 Oral Controlled Release Formulation for Sedatives and Hypnotic Agents  
The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic...
US20090110728 Zero-Order Modified Release Solid Dosage Forms  
The invention comprises a solid dosage form for delivery of water soluble pharmaceutical agents. The solid dosage form comprises a matrix core containing the pharmaceutical agent and a hydrophobic...
US20090110727 Extended release compositions of proton pump inhibitors  
The invention provides extended release compositions comprising at least one proton pump inhibitor. The invention also provides methods for treating gastrointestinal disorders by administering the...
US20090098202 Extended Release Formulation  
The invention is directed to an extended release formulation comprising pramipexole or a pharmaceutically acceptable salt thereof.
US20090092658 NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS  
The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability,...
US20090087487 Paliperidone sustained release formulation  
The present invention provides sustained release dosage forms comprising Paliperidone and processes for preparing the same.
US20090081291 Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User  
Aspects of the invention include a sustained release dosage form that can be administered to an oral cavity, e.g., the mouth. In certain embodiments, the sustained release dosage form is formulated...
US20090081290 TAMPER RESISTANT DOSAGE FORMS  
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of...
US20090074858 SUSTAINED-RELEASE FORMULATION  
A sustained-release formulation is provided comprising a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt thereof in a mixture comprising a...
US20090060994 Controlled release azithromycin solid dosages forms  
A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form.
US20090047346 Sustained release formulations of sotalol  
Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be...
US20090047345 Sustained-release tramadol formulations with 24-hour efficacy  
A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect...
US20090041844 Modified Release Formulation  
The invention is directed to the use of an extended release tablet formulation for pramipexole.
US20090035372 METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF AN ACTIVE SUBSTANCE  
The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene...
US20090035370 DOSAGE FORM AND METHOD OF USE  
A method for treating a medical condition for which quetiapine is indicated in a subject comprises comprising orally administering to the subject quetiapine or a pharmaceutically acceptable salt...
US20090028940 PHARMACEUTICAL COMPOSITIONS OF RIFAXIMIN  
A pharmaceutical composition comprising therapeutically effective amount of rifaximin or pharmaceutically acceptable salt or enantiomer or polymorph thereof, pharmaceutically acceptable...
US20090022790 TAMPER RESISTANT CO-EXTRUDED DOSAGE FORM CONTAINING AN ACTIVE AGENT AND AN ADVERSE AGENT AND PROCESS OF MAKING SAME  
The present invention relates to co-extruded pharmaceutical compositions and dosage forms including an active agent, such as an opioid agonist, and an adverse agent, such as an opioid antagonist....
US20090017116 EXTENDED RELEASE GLICLAZIDE FORMULATIONS  
The present invention relates to an extended release (XL) pharmaceutical tablet composition for oral administration and methods of its manufacture. More particularly, the present invention relates...
US20090017113 DULOXETINE FORMULATIONS  
Duloxetine pellets having an enteric coating containing a polymethacrylate polymer can be formed with desirable release rates/profile and stability.
US20090011017 POLYMERS BASED ON WATER-SOLUBLE MONOOLEFINIC COMPRISING COLLOIDAL SILICA AND THEIR USE AS MATRIX POLYMERS FOR SOLID DOSAGE FORMS  
Copolymers obtained by free-radical polymerization of a mixture of a) 80 to 99% by weight of a monoolefinic monomer selected fronm the group consisting of acrylic monomers, methacrylic...
US20090011016 Crush-Resistant Oxycodone Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion  
Water-insoluble matrix tablets based on oxycodone or one of its pharmaceutically acceptable salts and capable of prolonged release of oxycodone to the body, exhibiting a crush resistance of at...
US20090011011 STABLE DOSAGE FORMULATIONS OF IMIDAZOLYLALKYL-PYRIDINES  
Stable formulations of imidazolylalkyl-pyridines, including controlled-release formulations.
US20080311200 Controlled Slow Release Formulation of Thiamine and Use Thereof in the Treatment of Pathologies Connected to Defective Process of Learning and Memorization  
The present invention relates to thiamine controlled-release pharmaceutical compositions and their use in medicine for resolving absorption defects or deficiencies of thiamine itself from the...
US20080311187 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM  
The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or...
US20080305165 SUSTAINED RELEASE ORAL FORMULATION AND PROCESS FOR THE PREPARATION THEREOF  
Disclosed is a multiple unit type sustained release oral formulation comprising sustained release pellets formed from granules containing an active ingredient and a water-insoluble polymer, the...
US20080299196 Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester  
The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of...
US20080299195 USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE  
This invention is directed to the use of ranolazine to reduce the risk of adverse coronary events in a mammalian patient. Typically, the natriuretic peptide is associated with coronary disease,...
US20080292702 Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same  
A fused solid dispersion comprising an active ingredient having a melting point of 800 C or below and a pharmaceutically acceptable absorbent having a specific surface area ranging from 20 to 400...
US20080292700 CONTROLLED RELEASE FORMULATIONS USING INTELLIGENT POLYMERS  
A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent...
US20080292699 SOLID PHARMACEUTICAL DOSAGE UNIT FOR ALLEVIATING SYMPTOMS OF RHINORRHEA  
A solid pharmaceutical dosage unit for alleviating the symptoms of rhinorrhea. The dosage unit comprises an anticholinergic agent and an antihistamine and, optionally, a decongestant and, when...
US20080286358 Wake up on time dietary supplement and method of use  
A time-released dietary supplement is disclosed. The dietary supplement is meant be taken upon going to bed in the evening. The active ingredients are released during the night so the person will...
US20080286357 MULTI-FUNCTIONAL PARTICULATE DELIVERY SYSTEM FOR PHARMACOLOGICALLY ACTIVE INGREDIENTS  
The present invention relates to a pharmacologic dosage unit which includes a multi-functional particulate system and a pharmacologically active agent. The multi-functional particulate system...
US20080286344 Solid form  
A solid form comprising at least one film enrobing a compacted fill material wherein: i) the compacted fill material comprises at least one active material; ii) the solid form shows a weight...
Matches 1 - 50 out of 120 1 2 3 >